Sarclisa approved in the US as the first anti-CD38 therapy ... Drug Administration said on Friday it has approved the use of a drug combination along with Sanofi's Sarclisa infusion as a ...
Sanofi said the Food and Drug Administration has approved Sarclisa as a first line combined treatment option for adult patients with newly diagnosed multiple myeloma who aren't eligible for autologous ...